IPS HEART receives FDA Rare Pediatric Drug Designations for both of its Stem Cell Drugs for Duchenne Muscular Dystrophy Read more
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies Read more
Tiziana Life Sciences to Pursue Development of Intranasal Foralumab for the Treatment of Long COVID Read more
ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology with Leucid Bio Read more
PharmaLex expands Australia footprint through merger plan with pharmacovigilance leader Cpharm Read more
Cognizant and Boehringer Ingelheim Collaborate on Unified Cloud Platform to Speed the Delivery of Life Saving Therapies Read more
Fusion Pharmaceuticals Announces IND Clearance For FPI-2068, A Jointly Developed Novel Targeted Alpha Therapy Read more
Panbela Regains Worldwide Rights to Develop and Commercialize FlynpoviTM in Patients with Familial Adenomatous Polyposis (FAP) Read more
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI Read more
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders Read more